Cargando…

Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies

BACKGROUND AND PURPOSE: Intensity modulated radiotherapy (IMRT) is a powerful tool, which might go a long way in reducing radiation doses to critical structures and thereby reduce long term morbidities. The purpose of this paper is to evaluate the impact of IMRT in reducing the dose to the critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataria, Tejinder, Rawat, Sheh, Sinha, SN, Garg, C, Bhalla, NK, Negi, PS
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574325/
https://www.ncbi.nlm.nih.gov/pubmed/16939650
http://dx.doi.org/10.1186/1748-717X-1-31
_version_ 1782130286565261312
author Kataria, Tejinder
Rawat, Sheh
Sinha, SN
Garg, C
Bhalla, NK
Negi, PS
author_facet Kataria, Tejinder
Rawat, Sheh
Sinha, SN
Garg, C
Bhalla, NK
Negi, PS
author_sort Kataria, Tejinder
collection PubMed
description BACKGROUND AND PURPOSE: Intensity modulated radiotherapy (IMRT) is a powerful tool, which might go a long way in reducing radiation doses to critical structures and thereby reduce long term morbidities. The purpose of this paper is to evaluate the impact of IMRT in reducing the dose to the critical normal tissues while maintaining the desired dose to the volume of interest for thoracic malignancies. MATERIALS AND METHODS: During the period January 2002 to March 2004, 12 patients of various sites of malignancies in the thoracic region were treated using physical intensity modulator based IMRT. Plans of these patients treated with IMRT were analyzed using dose volume histograms. RESULTS: An average dose reduction of the mean values by 73% to the heart, 69% to the right lung and 74% to the left lung, with respect to the GTV could be achieved with IMRT. The 2 year disease free survival was 59% and 2 year overall survival was 59%. The average number of IMRT fields used was 6. CONCLUSION: IMRT with inverse planning enabled us to achieve desired dose distribution, due to its ability to provide sharp dose gradients at the junction of tumor and the adjacent critical organs.
format Text
id pubmed-1574325
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15743252006-09-23 Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies Kataria, Tejinder Rawat, Sheh Sinha, SN Garg, C Bhalla, NK Negi, PS Radiat Oncol Methodology BACKGROUND AND PURPOSE: Intensity modulated radiotherapy (IMRT) is a powerful tool, which might go a long way in reducing radiation doses to critical structures and thereby reduce long term morbidities. The purpose of this paper is to evaluate the impact of IMRT in reducing the dose to the critical normal tissues while maintaining the desired dose to the volume of interest for thoracic malignancies. MATERIALS AND METHODS: During the period January 2002 to March 2004, 12 patients of various sites of malignancies in the thoracic region were treated using physical intensity modulator based IMRT. Plans of these patients treated with IMRT were analyzed using dose volume histograms. RESULTS: An average dose reduction of the mean values by 73% to the heart, 69% to the right lung and 74% to the left lung, with respect to the GTV could be achieved with IMRT. The 2 year disease free survival was 59% and 2 year overall survival was 59%. The average number of IMRT fields used was 6. CONCLUSION: IMRT with inverse planning enabled us to achieve desired dose distribution, due to its ability to provide sharp dose gradients at the junction of tumor and the adjacent critical organs. BioMed Central 2006-08-29 /pmc/articles/PMC1574325/ /pubmed/16939650 http://dx.doi.org/10.1186/1748-717X-1-31 Text en Copyright © 2006 Kataria et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Kataria, Tejinder
Rawat, Sheh
Sinha, SN
Garg, C
Bhalla, NK
Negi, PS
Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies
title Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies
title_full Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies
title_fullStr Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies
title_full_unstemmed Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies
title_short Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies
title_sort dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574325/
https://www.ncbi.nlm.nih.gov/pubmed/16939650
http://dx.doi.org/10.1186/1748-717X-1-31
work_keys_str_mv AT katariatejinder dosereductiontonormaltissuesascomparedtothegrosstumorbyusingintensitymodulatedradiotherapyinthoracicmalignancies
AT rawatsheh dosereductiontonormaltissuesascomparedtothegrosstumorbyusingintensitymodulatedradiotherapyinthoracicmalignancies
AT sinhasn dosereductiontonormaltissuesascomparedtothegrosstumorbyusingintensitymodulatedradiotherapyinthoracicmalignancies
AT gargc dosereductiontonormaltissuesascomparedtothegrosstumorbyusingintensitymodulatedradiotherapyinthoracicmalignancies
AT bhallank dosereductiontonormaltissuesascomparedtothegrosstumorbyusingintensitymodulatedradiotherapyinthoracicmalignancies
AT negips dosereductiontonormaltissuesascomparedtothegrosstumorbyusingintensitymodulatedradiotherapyinthoracicmalignancies